#CanadaUSBorder; #MixedCovid19Vaccines; #CDC; #WHO
Ottawa/Canada: News of reopening of Canada-U.S. border in early Nov is welcoming but brings with it uncertainty to several Canadians who have had mixed COVID-19 vaccines.
Representative image of US border / credit: Unsplash
This is due to the fact that mixed COVID-19 vaccines, such as one dose of AstraZeneca and one dose of Pfizer or Moderna are not currently recognized by the U.S. Centers for Disease Control (CDC)
CDC hasn't yet confirmed if travelers with two different doses will be barred from entry after vaccine requirement kicks in.
"CDC will release additional guidance and information as the travel requirements are finalized later this month," said spokesperson Jade Fulce in an email on Wednesday.
U.S.' acceptance of visitors inoculated with COVID-19 vaccines authorized by U.S. regulators or the World Health Organization (WHO), which included AstraZeneca and its Indian-made counterpart, Covishield was confirmed last week by CDC.
Although a similar rule is expected at land crossings, the U.S. is still waiting for CDC's guidance about travelers with mixed doses.
Although CDC currently does not recognize mixed vaccines, CDC's website says that in "exceptional situations" such as when the vaccine used for the first dose was no longer available, mixed doses of the two mRNA vaccines, Pfizer and Moderna, are acceptable.